Gene-editing therapy that could cure blood disorder thalassaemia for NHS patients
NHS patients living with a genetic blood disorder are set to be among the first in the world to benefit from a “life-changing” gene-editing treatment which offers hope of a cure. The one-off gene therapy, Casgevy, has been approved by for use on the NHS in England, from today (8 August), by the National Institute […]